PSA
38
-2
ICE
59
-3
VIX
46
-6
LLY
60
6
GOOGL
48
5
AMGN
33
12
PCAR
27
-7
LEN
22
8
ES
40
-2
CTAS
50
-2
NOC
48
-3
MOS
52
2
IVZ
39
3
KIM
54
17
ZION
59
2
AMAT
58
-3
CAT
46
4
PNW
52
-3
DE
58
2
EL
43
-2
PSA
38
-2
ICE
59
-3
VIX
46
-6
LLY
60
6
GOOGL
48
5
AMGN
33
12
PCAR
27
-7
LEN
22
8
ES
40
-2
CTAS
50
-2
NOC
48
-3
MOS
52
2
IVZ
39
3
KIM
54
17
ZION
59
2
AMAT
58
-3
CAT
46
4
PNW
52
-3
DE
58
2
EL
43
-2
Financhill
Back

Praxis Precision Medicines Stock Predictions

How to hack a $1.3T market

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
47

PRAX
Praxis Precision Medicines

Last Price:
$42.36
Seasonality Move:
27.39%

7 Day Trial

ALL ACCESS PASS

$ 7

Former Zillow exec targets $1.3T marke

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa

Praxis Precision Medicines Stock Forecast

  • Over the next 52 weeks, Praxis Precision Medicines has on average historically risen by 1.6% based on the past 4 years of stock performance.
  • Praxis Precision Medicines has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Praxis Precision Medicines Stock Undervalued?
    The current Praxis Precision Medicines [PRAX] share price is $42.97. The Score for PRAX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • PRAX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Praxis Precision Medicines Stock Go Up Next Year?

  • Over the next 52 weeks, Praxis Precision Medicines has on average historically risen by 1.6% based on the past 4 years of stock performance.

Praxis Precision Medicines Stock Rating

Sell
47
Praxis Precision Medicines (PRAX) is a Sell

Is Praxis Precision Medicines overpriced?

  • Praxis Precision Medicines has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Praxis Precision Medicines Stock Price History

Is PRAX stock going to rise?

  • The current trend is moderately bullish and PRAX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
praxismedicines.com

52-Week Data

52-Week High:
91.83
52-Week Low:
26.70

Prediction Charts

Market Cap:
875.3M
Price in USD:
42.97
Volume:
254.9K
Beta:
2.62

Technical Analysis

SMA50:
37.81
SMA100:
47.02
SMA200:
58.31
52-Wk Change:
14.01%

Stock Predictions

  • Is Praxis Precision Medicines stock public?
    Yes, Praxis Precision Medicines is a publicly traded company.
  • What is the Praxis Precision Medicines stock quote today?
    The Praxis Precision Medicines stock price is 42.97 USD today.
  • How to buy Praxis Precision Medicines stock online?
    You can buy Praxis Precision Medicines shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-30 38.19 38.55 38.79 36.30
Jun-2 39.00 39.82 40.30 37.55
Jun-3 39.90 41.20 41.27 39.00
Jun-4 41.26 41.37 42.67 40.93
Jun-5 40.83 42.26 45.85 40.57
Jun-6 42.84 44.56 45.89 42.12
Jun-9 45.45 44.51 45.45 43.44
Jun-10 44.49 45.85 46.09 43.49
Jun-11 46.12 44.60 46.93 44.56
Jun-12 44.01 45.03 46.06 43.44
Jun-13 43.66 44.30 45.80 43.66
Jun-16 44.76 43.81 44.76 43.03
Jun-17 43.35 43.46 44.26 41.64
Jun-18 43.55 42.97 44.99 42.61

Praxis Precision Medicines Earnings

Praxis Precision Medicines Earnings Report: Per Share Praxis Precision Medicines Earnings Q1 Q2 Q3 and Q4 last year and next year.

Praxis Precision Medicines Forecast Revenue Growth

Praxis Precision Medicines Stock Analysis: Historical quarterly revenues per share for Praxis Precision Medicines and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $1.30 per share, a decrease next quarter of $0.25 per share, a decrease this year of $2.90 per share, and an increase next year of $0.93 per share.

* Praxis Precision Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.